Skip to main content
EM

Emulate

Boston, United States
Last funding
$47.1M
Series FMar 2024

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

About Emulate

How much funding has Emulate raised?

Emulate has raised $47.1M in total funding. The most recent round was Series F. The last funding was announced in March 2024.

Who are Emulate's investors?

Emulate's investors include Alumni Ventures, Founders Fund, Qiming Venture Partners, Perceptive Advisors, Starlight Ventures.

Where is Emulate headquartered?

Emulate is headquartered in Boston, United States.

What does Emulate do?

Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.

What stage is Emulate at?

Emulate is at the Series F stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Emulate — Funding & Investors." VCBacked, March 20, 2024, https://www.vcbacked.co/company/emulate. Accessed November 14, 2026.
APA
VCBacked. (2024). Emulate — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/emulate
Wikipedia (cite web)
{{cite web |title=Emulate — Funding & Investors |url=https://www.vcbacked.co/company/emulate |website=VCBacked |access-date=November 14, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Emulate? Request a listing update

Founder contacts
m***@emulatebio.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →